Rhoades, PhD, of MedVal Scientific Information Services, LLC, for providing editorial assistance
Potential for Symptom Improvement For Some with IBS-D: Slower gastric emptying and smaller meals may reduce post-meal urgency, frequency, and diarrhea triggered by large or rapid food intake
Medical Expert, This is just the start
j , Body weight (n = 8 each group)
North Texas Research Forum 2025 Files Download Full Text (492 KB) Division North Texas Hospital Medical City Arlington Specialty Obstetrics & Gynecology Document Type Poster Publication Date 2025 Keywords non-arteriticanterior ischemic optic neuropathy, semaglutide, type 2 diabetes, weight loss, GLP-1RA Disciplines Internal Medicine | Medicine and Health Sciences | Obstetrics and Gynecology Abstract Background: Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-RA), was introduced and approved by the United States Food and Drug Administration (FDA) for the management of type 2 diabetes in 2017